Literature DB >> 7771818

Current role of surgery in Mycobacterium tuberculosis.

R L Treasure1, B J Seaworth.   

Abstract

From January 1986 through December 1993, we operated on 59 patients with documented Mycobacterium tuberculosis infection. Indications for operation were as follows: multidrug-resistant tuberculosis (MDRTB) in 19 patients; bronchopleural fistula secondary to Mycobacterium tuberculosis infection in 12; massive hemoptysis in 5; destroyed lung in 7; solitary nodule in 7; trapped lung in 3; complicated cavity in 4; and empyema in 2. Sixty-five operative procedures were performed: pneumonectomy with latissimus muscle flap in 15 patients; pneumonectomy in 3; lobectomy in 16; segmental or wedge resection in 11; decortication in 5; window thoracostomy in 3; thoracoplasty with myoplasty in 4; tube thoracostomy in 4; return to operating room for bleeding in 2; Clagett procedure in 1; and drainage of a cold abscess in 1. There were no operative deaths. Major postoperative complications occurred in 5 patients. The two late deaths were in patients with MDRTB: 1 with progressive disease and massive hemoptysis and the other with a relapse of MDRTB. Of the patients operated on as part of their therapeutic regimen for MDRTB, 17 (89%) of 19 have remained culture negative. We conclude that (1) surgery still plays an important role in the management of patients with Mycobacterium tuberculosis infection; (2) surgical intervention can be performed with acceptable mortality and morbidity; (3) a variety of procedures are needed to effect cure; and (4) encouraging results in patients with MDRTB support surgical therapy in this difficult group of patients.

Entities:  

Mesh:

Year:  1995        PMID: 7771818     DOI: 10.1016/0003-4975(95)00145-b

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

Review 2.  Resurgence of therapeutically destitute tuberculosis: amalgamation of old and newer techniques.

Authors:  Ravindra Kumar Dewan; Loven Moodley
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru.

Authors:  Jose G Somocurcio; Alfredo Sotomayor; Sonya Shin; Silvia Portilla; Maria Valcarcel; Dalia Guerra; Jennifer Furin
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

4.  Approach to empyema necessitatis.

Authors:  Asli Gül Akgül; Alpay Örki; Tülay Örki; Mustafa Yüksel; Bülent Arman
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

5.  Video thoracoscopic surgery used to manage tuberculosis in thoracic surgery.

Authors:  M Beshay; P Dorn; J R Kuester; G L Carboni; M Gugger; R A Schmid
Journal:  Surg Endosc       Date:  2005-06-23       Impact factor: 4.584

6.  Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.

Authors:  Shelley E Haydel
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-01

7.  Tuberculosis chemotherapy in the 21 century: Back to the basics.

Authors:  Jyotsna M Joshi
Journal:  Lung India       Date:  2011-07

8.  The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis.

Authors:  Hongyun Ruan; Changfan Gong; Jinxiang Wang
Journal:  World J Surg       Date:  2021-02-08       Impact factor: 3.352

9.  Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment.

Authors:  Hongyun Ruan; Fangchao Liu; Yunsong Li; Yuxuan Wang; Dongdong Hou; Xinting Yang; Bin Liu; Teng Ma; Zhidong Liu
Journal:  BMC Pulm Med       Date:  2022-09-14       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.